halofuginone

transforming growth factor, beta 1 ; Mus musculus







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29156807 Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. 2017 Oct 17 2
2 26787621 Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model. 2016 Apr 1
3 27021682 Halofuginone alleviates acute viral myocarditis in suckling BALB/c mice by inhibiting TGF-β1. 2016 Apr 29 1
4 27533085 Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer. 2016 Nov 1 3
5 26099922 Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. 2015 Jun 23 1
6 26664138 Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer. 2015 3
7 23002206 Halofuginone inhibits the establishment and progression of melanoma bone metastases. 2012 Dec 1 4
8 22053203 Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway. 2011 1
9 19114027 Halofuginone prevents extracellular matrix deposition in diabetic nephropathy. 2009 Feb 6 3
10 19188864 Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. 2009 May 1
11 19578745 Halofuginone mediated protection against radiation-induced leg contracture. 2009 Aug 3
12 18672370 Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone. 2008 Nov 1
13 14732719 Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. 2004 Apr 9 3